MARKET

ABMD

ABMD

Abiomed
NASDAQ

Real-time Quotes | Nasdaq Last Sale

317.95
-0.62
-0.19%
Opening 09:38 06/21 EDT
OPEN
318.18
PREV CLOSE
318.57
HIGH
318.18
LOW
316.05
VOLUME
3.13K
TURNOVER
--
52 WEEK HIGH
387.40
52 WEEK LOW
234.39
MARKET CAP
14.40B
P/E (TTM)
64.39
1D
5D
1M
3M
1Y
5Y
Abiomed Inc. stock outperforms market on strong trading day
marketwatch.com · 2d ago
Deutsche Bank Starts Abiomed at Buy With $360 Price Target
MT Newswires · 3d ago
Abiomed Inc. stock underperforms Tuesday when compared to competitors
marketwatch.com · 5d ago
What Does Abiomed, Inc.'s (NASDAQ:ABMD) Share Price Indicate?
Abiomed, Inc. ( NASDAQ:ABMD ) saw a decent share price growth in the teens level on the NASDAQGS over the last few...
Simply Wall St. · 6d ago
Abiomed Inc. stock rises Friday, outperforms market
marketwatch.com · 06/11 20:33
DSMB recommends Abiomed trial for heart pump in cardiogenic shock continue
SDI Productions/E+ via Getty Images A Data Safety Monitoring Board ("DSMB") has recommended that Abiomed's (ABMD) DanGer Shock trial of its Impella CP heart pump in patients with cardiogenic shock
Seekingalpha · 06/08 17:04
Abiomed's (ABMD) preCARDIA Buyout Expands Its Product Portfolio
Abiomed's (ABMD) latest acquisition is expected to improve patient outcome as well as lower the cost of care.
Zacks · 06/03 14:40
Abiomed Inc. stock outperforms competitors on strong trading day
Shares of Abiomed Inc. inched 0.21% higher to $280.28 Wednesday, on what proved to be an all-around great trading session for the stock market, with the S&P...
marketwatch.com · 06/02 20:33
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ABMD. Analyze the recent business situations of Abiomed through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average ABMD stock price target is 374.00 with a high estimate of 425.00 and a low estimate of 245.00.
EPS
Institutional Holdings
Institutions: 713
Institutional Holdings: 46.85M
% Owned: 103.43%
Shares Outstanding: 45.30M
TypeInstitutionsShares
Increased
157
2.03M
New
47
402.06K
Decreased
185
2.06M
Sold Out
55
1.72M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Advanced Medical Equipment & Technology
-0.37%
Healthcare Equipment & Supplies
-0.32%
Key Executives
Chairman/Director/President/Chief Executive Officer
Michael Minogue
Chief Financial Officer/Vice President
Todd Trapp
Chief Operating Officer/Senior Vice President
David Weber
Vice President/General Counsel/Secretary
Marc Began
Vice President/General Manager
Michael Howley
Vice President
Andrew Greenfield
Lead Director/Independent Director
Dorothy Puhy
Director
Paula Johnson
Director
Myron Rolle
Independent Director
Jeannine Rivet
Independent Director
Eric Rose
Independent Director
Martin Sutter
Independent Director
Paul Thomas
Independent Director
Christopher Van Gorder
No Data
About ABMD
ABIOMED, Inc. is a provider of temporary percutaneous mechanical circulatory support devices. The Company offers care to heart failure patients. The Company operates in the segment of the research, development and sale of medical devices to assist or replace the pumping function of the failing heart. The Company develops, manufactures and markets products that are designed to enable the heart to rest, heal and recover by improving blood flow to the coronary arteries and end-organs and/or temporarily performing the pumping function of the heart. The Company's product portfolio includes the Impella 2.5, Impella CP, Impella RP, Impella LD, Impella 5.0 and AB5000. The Company's products are used in the cardiac catheterization lab (cath lab), by interventional cardiologists, the electrophysiology lab, the hybrid lab and in the heart surgery suite by heart surgeons.

Webull offers kinds of ABIOMED, Inc. stock information, including NASDAQ:ABMD real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABMD stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ABMD stock methods without spending real money on the virtual paper trading platform.